本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

10.22
-0.2000-1.92%
盤後10.15-0.0700-0.68%19:30 EDT
成交量:22.84萬
成交額:234.34萬
市值:5.00億
市盈率:-3.19
高:10.61
開:10.49
低:10.10
收:10.42
52周最高:14.53
52周最低:2.22
股本:4,888.58萬
流通股本:1,927.60萬
量比:0.75
換手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
淨資產收益率:-36.58%
總資產收益率:-22.34%
市淨率:1.44
市盈率(LYR):-2.98

資料載入中...

2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/22

重要事件披露

Form 8-K - Current report
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/29

重要事件披露

Form 8-K - Current report
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/17

SEC問詢函

Form CORRESP - Correspondence